Bollard Group’s Can-Fite BioPharma American Depositary Shares CANF Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2015
Q4
Sell
-3
Closed -$32K 261
2015
Q3
$32K Buy
+3
New +$20.1K ﹤0.01% 241

Other funds holding CANF

Bollard Group's CANF Position: Q4 2015 in Review

Bollard Group sold out of Can-Fite BioPharma American Depositary Shares (CANF) in Q4 2015, closing a stake of 3 shares — an estimated $32K sold.

Bollard Group first reported a position in CANF in Q3 2015 and held it in 1 quarter. The position peaked at $32K in Q3 2015. 8 funds tracked by Wall St. Rank hold CANF as of Q4 2015.

  • Bollard Group reported no remaining Can-Fite BioPharma American Depositary Shares position as of Q4 2015 after selling out during the quarter.
  • Bollard Group sold 3 Can-Fite BioPharma American Depositary Shares shares in Q4 2015, an estimated $32K.
  • Bollard Group first reported a position in Can-Fite BioPharma American Depositary Shares in Q3 2015 and held it in 1 quarter.
  • Bollard Group's Can-Fite BioPharma American Depositary Shares position peaked at $32K in Q3 2015.
  • 8 funds tracked by Wall St. Rank held Can-Fite BioPharma American Depositary Shares as of Q4 2015.

Based on Bollard Group's 13F filing for Q4 2015, filed 4 Feb 2016.